Sign in

CIK 0001621227

  • Non-accelerated filer
  • Smaller reporting company

Adaptimmune Therapeutics PLC

Sign in to watch
Ticker
ADAPY
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
United Kingdom
Entity type
Operating
Phone
+44 1235430000
Business address
60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
Former names
Adaptimmune Ltd
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2018-06-06 Thompson Peter A. Director Sale −1,600 $13.49 $22K 4,901,310
2018-06-04 Thompson Peter A. Director Sale −17,100 $13.57 $232K 4,902,910
2018-06-01 Thompson Peter A. Director Sale −50,000 $13.49 $675K 4,920,010
2018-05-30 Thompson Peter A. Director Sale −121,000 $13.52 $1.6M 4,970,010
2018-05-14 Thompson Peter A. Director Sale −10,300 $13.50 $139K 5,091,010
2018-03-29 Thompson Peter A. Director Sale −31,983 $11.53 $369K 5,101,310
2018-03-27 Thompson Peter A. Director Sale −1,016,084 $11.50 $11.7M 5,133,293
2017-07-03 Thompson Peter A. Director Grant or award · Option to purchase Ordinary Shares +223,779 223,779
2017-03-27 Thompson Peter A. Director Purchase +1,190,476 $4.20 $5.0M 6,149,377
2016-08-11 Thompson Peter A. Director Grant or award · Option to purchase Ordinary Shares +186,142 186,142
2016-05-24 Thompson Peter A. Director Purchase +518,400 $10.48 $5.4M 29,753,404
2016-05-23 Thompson Peter A. Director Purchase +1,191,600 $10.40 $12.4M 29,235,004
2016-05-20 Thompson Peter A. Director Purchase +2,400 $10.04 $24K 28,043,404

Page 1 of 1 · 13 trades